This article was originally published in The Tan Sheet
Chief Operating Officer Ian Cook will succeed President William Shanahan upon his retirement Sept. 30, the firm reports. Colgate announced the appointment earlier this year, signaling Cook was a likely contender to replace CEO Reuben Mark, who said in 2004 he planned to step down in two to four years ("The Tan Sheet" Feb. 9, 2004, p. 7). Cook will retain his COO title. Separately, Colgate released its second quarter results July 27. Oral care, personal care and home care sales grew 11% to $2.46 bil., and operating profit in the segment was up 4% to $527.4 mil. Net sales for the quarter grew 10.5% to $2.84 bil., but net income including restructuring charges fell 8% to $342.9 mil...
You may also be interested in...
Colgate-Palmolive President and COO Ian Cook will take over the chief executive position after current Chairman and CEO Reuben Mark retires in 2007, according to Mark
Zydus Cadila is to begin testing a three-dose recombinant DNA vaccine candidate in Phase III Indian trials, which might enter late-stage development ahead of Inovio and AnGes. The company promised to provide 100-150 million doses by end of 2021 at the J.P. Morgan Conference, though adherence could be a roadblock.
Sun Pharma’s founder and MD shares with Scrip his views on some key big picture issues, including leveraging pandemic-related regulatory experience for urgently needed products, expectations in the US market, the outlook for M&A, and the potential of e-pharmacies in India.